Aug 20, 2026 05:00PM
Aug 13, 2026 05:30PM
May 14, 2026 06:00PM
May 7, 2026 06:11PM
Mar 19, 2026 05:30PM
Mar 12, 2026 05:30PM
Feb 9, 2026 07:30AM BioSyent to acquire Oral Science for $25.5 million in cash and stock
Feb 9, 2026 07:30AM
Dec 15, 2025 04:30PM
Nov 20, 2025 05:30PM
Nov 13, 2025 04:05PM
Aug 21, 2025 04:45PM
Aug 14, 2025 05:00PM
May 15, 2025 05:45PM BioSyent Releases Financial Results for First Quarter 2025
May 8, 2025 04:30PM
Mar 13, 2025 05:30PM
Mar 6, 2025 05:45PM
Dec 16, 2024 08:30AM
Nov 20, 2024 08:00AM
Nov 13, 2024 04:30PM
Sep 20, 2024 09:00AM BioSyent Announces Agreement to Purchase Tibelia® (tibolone) Assets
Aug 26, 2024 04:45PM
May 16, 2024 06:30PM
May 9, 2024 04:30PM
Mar 13, 2024 05:30PM
Mar 6, 2024 04:30PM
Dec 13, 2023 08:00AM
Nov 16, 2023 08:00AM BioSyent Releases Q3 and YTD 2023 Financial Results
Nov 9, 2023 08:00AM
Aug 22, 2023 04:15PM
Aug 15, 2023 04:30PM
May 26, 2023 08:00AM
May 18, 2023 08:30AM
Mar 21, 2023 04:30PM
Mar 9, 2023 04:30PM BioSyent Schedules Q4 and Full Year 2022 Earnings Release for March 21, 2023
Dec 13, 2022 08:00AM
Nov 16, 2022 07:07PM
Nov 10, 2022 09:00AM
Aug 23, 2022 04:45PM
Aug 16, 2022 07:14PM
May 18, 2022 08:00AM
May 10, 2022 04:30PM BioSyent Schedules Q1 2022 Earnings Release for May 18, 2022
Mar 29, 2022 05:37PM
Mar 9, 2022 04:34PM
Mar 3, 2022 04:28PM
Dec 13, 2021 08:00AM
Nov 18, 2021 05:00PM
Nov 10, 2021 08:00AM
Aug 25, 2021 08:00AM BioSyent Releases Q2 and H1 2021 Financial Results
Aug 17, 2021 08:00AM

1,220,826 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All